Sofinnova Management VIII, L.L.C. 13F-HR Quarterly holdings report by institutional manager

The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE

OMB APPROVAL

OMB Number:		3235-0006
Expires:	Oct 31, 2018
Estimated average burden
hours per response:		23.8

COLUMN 1	COLUMN 2	COLUMN 3	COLUMN 4	COLUMN 5			COLUMN 6	COLUMN 7	COLUMN 8
			VALUE	SHRS OR	SH/	PUT/	INVESTMENT	OTHER	VOTING AUTHORITY
NAME OF ISSUER	TITLE OF CLASS	CUSIP	(x$1000)	PRN AMT	PRN	CALL	DISCRETION	MANAGER	SOLE	SHARED	NONE
Natera, Inc.	Common Stock	632307104	16,836	1,550,280	SH		SOLE		1,550,280	0	0
Mirna Therapeutics, Inc.	Common Stock	60470J103	4,968	2,974,812	SH		SOLE		2,974,812	0	0
Versartis, Inc.	Common Stock	92529L102	27,279	1,563,260	SH		SOLE		1,563,260	0	0
Innocoll Holdings PLC	Ordinary Shares	G4783X105	4,795	2,103,173	SH		SOLE		2,103,173	0	0
Aclaris Therapeutics, Inc.	Common Stock	00461U105	41,751	1,539,480	SH		SOLE		1,539,480	0	0
Auris Medical Holding AG	Common Shares	H03579101	5,629	7,818,175	SH		SOLE		7,818,175	0	0
Histogenics Corporation	Common Stock	43358V109	3,718	2,077,040	SH		SOLE		2,077,040	0	0
Spark Therapeutics, Inc.	Common Stock	84652J103	41,407	693,128	SH		SOLE		693,128	0	0
ObsEva SA	Common Stock	H5861P103	32,059	3,749,623	SH		SOLE		3,749,623	0	0